CD63 and cancer: Taken together, these results indicated that the xenograft mouse model bearing CD63-Antares2-expressing cancer cells allows monitoring long-term circulating cancer-derived exosomes quantitatively and in a time-dependent manner, and visualizing exosome-homing organs, tissues, and cells.